Biomarkers of coronary artery disease: the promise of the transcriptome
Standard
Biomarkers of coronary artery disease: the promise of the transcriptome. / Siemelink, Marten Antoon; Zeller, Tanja.
in: CURR CARDIOL REP, Jahrgang 16, Nr. 8, 08.2014, S. 513.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Biomarkers of coronary artery disease: the promise of the transcriptome
AU - Siemelink, Marten Antoon
AU - Zeller, Tanja
PY - 2014/8
Y1 - 2014/8
N2 - The last years have witnessed tremendous technical advances in the field of transcriptomics that enable the simultaneous assessment of nearly all transcripts expressed in a tissue at a given time. These advances harbor the potential to gain a better understanding of the complex biological systems and for the identification and development of novel biomarkers. This article will review the current knowledge of transcriptomics biomarkers in the cardiovascular field and will provide an overview about the promises and challenges of the transcriptomics approach for biomarker identification.
AB - The last years have witnessed tremendous technical advances in the field of transcriptomics that enable the simultaneous assessment of nearly all transcripts expressed in a tissue at a given time. These advances harbor the potential to gain a better understanding of the complex biological systems and for the identification and development of novel biomarkers. This article will review the current knowledge of transcriptomics biomarkers in the cardiovascular field and will provide an overview about the promises and challenges of the transcriptomics approach for biomarker identification.
KW - Biomarkers/analysis
KW - Coronary Artery Disease/diagnosis
KW - Gene Expression Profiling/methods
KW - Genomics/methods
KW - Humans
KW - Transcriptome
U2 - 10.1007/s11886-014-0513-4
DO - 10.1007/s11886-014-0513-4
M3 - SCORING: Review article
C2 - 24950674
VL - 16
SP - 513
JO - CURR CARDIOL REP
JF - CURR CARDIOL REP
SN - 1523-3782
IS - 8
ER -